Literature DB >> 1633079

Do nitrates differ?

H L Fung1.   

Abstract

1. The organic nitrates all share a common biochemical and physiological mechanism of action. 2. The organic nitrates differ substantially in their pharmacologic potency and pharmacokinetics. In vitro potency differences appear larger than the corresponding in vivo activities. 3. The duration of action of organic nitrates, after a single immediate-release dose, is governed by the pharmacokinetics of the drug. However, the duration of action of available sustained-release preparations, whatever the nitrate or formulation, is limited to about 12 h, due to the development of pharmacologic tolerance. 4. Nitrates do not appear to differ in their production of undesirable effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633079      PMCID: PMC1381215          DOI: 10.1111/j.1365-2125.1992.tb04141.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Glutathione S-transferase in the formation of cyanide from organic thiocyantes and as an organic nitrate reductase.

Authors:  W H Habig; J H Keen; W B Jakoby
Journal:  Biochem Biophys Res Commun       Date:  1975-05-19       Impact factor: 3.575

2.  Cardiac output is an apparent determinant of nitroglycerin pharmacokinetics in rats.

Authors:  H L Fung; A Blei; S Chong
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

3.  Guanylate cyclase activation by organic nitrates is not mediated via nitrite.

Authors:  C Romanin; W R Kukovetz
Journal:  J Mol Cell Cardiol       Date:  1988-05       Impact factor: 5.000

4.  Purification and characterization of glutathione transferases with an activity toward nitroglycerin from human aorta and heart. Multiplicity of the human class Mu forms.

Authors:  S Tsuchida; T Maki; K Sato
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

5.  Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells.

Authors:  S J Chung; H L Fung
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

6.  Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.

Authors:  L J Ignarro; H Lippton; J C Edwards; W H Baricos; A L Hyman; P J Kadowitz; C A Gruetter
Journal:  J Pharmacol Exp Ther       Date:  1981-09       Impact factor: 4.030

7.  Investigation on structure-activity relationship in organic nitrates.

Authors:  E Noack
Journal:  Methods Find Exp Clin Pharmacol       Date:  1984-10

8.  Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure.

Authors:  M T Olivari; P F Carlyle; T B Levine; J N Cohn
Journal:  J Am Coll Cardiol       Date:  1983-11       Impact factor: 24.094

9.  Requirement for heme in the activation of purified guanylate cyclase by nitric oxide.

Authors:  P A Craven; F R DeRubertis
Journal:  Biochim Biophys Acta       Date:  1983-06-29

Review 10.  Nitrate therapy: is there an optimal substance and formulation?

Authors:  H L Fung
Journal:  Eur Heart J       Date:  1991-05       Impact factor: 29.983

View more
  2 in total

Review 1.  A review of chronic anal fissure management.

Authors:  E E Collins; J N Lund
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

2.  Nitrate induced coronary vasodilatation: differential effects of sublingual application by capsule or spray.

Authors:  M Pfister; C Seiler; M Fleisch; H Göbel; T Lüscher; B Meier
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.